Thromb Res 2021[Jan]; 197 (?): 202-204 PMID33260043show ga
* We report a translational experience of a cardiovascular department facing MACE in COVID-19 patients. * Acute arterial events are the real emergency into this COVID-19 pandemic. * COVID-19 infection may trigger a hypercoagulable status leading to MACE and high mortality rate. * In this COVID-19 outbreak, the adjunct of heparin provides better survival chance independently of the infection-related drug treatment.